(Q43583258)

24 November 2017

title

Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression (English)

1 reference

24 November 2017

1 reference

1 reference

1

1 reference

24 November 2017

Bulur PA

2

1 reference

24 November 2017

Brown CA

series ordinal

3

1 reference

24 November 2017

Pankratz VS

series ordinal

4

1 reference

24 November 2017

Vuk-Pavlovic S

series ordinal

5

1 reference

24 November 2017

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

8

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

419-423

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301406

24 November 2017

exact match

0 references

cites work

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

7 January 2021

Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

7 January 2021

Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

7 January 2021

Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

7 January 2021

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301406

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301406

1 reference

Dimensions Publication ID

24 November 2017

1026575808

0 references

1 reference